These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 93978)

  • 21. Current concepts in management of testicular tumor.
    Javadpour N
    Urol Surv; 1978 Jun; 28(3):89-94. PubMed ID: 80873
    [No Abstract]   [Full Text] [Related]  

  • 22. Prognostic factors in metastatic disease.
    Droz JP; Kramar A; Rey A
    Semin Oncol; 1992 Apr; 19(2):181-9. PubMed ID: 1372760
    [No Abstract]   [Full Text] [Related]  

  • 23. Significance of tumour markers in ovarian cancer.
    Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH
    Indian J Cancer; 1987 Mar; 24(1):1-8. PubMed ID: 2448222
    [No Abstract]   [Full Text] [Related]  

  • 24. [Value of tumor marker positivity in germinal non-seminomatous tumors of the testis].
    Bassetto MA; Franceschi T; Lenotti M; Pancheri F; Zaninelli M; Corgnati A; Cetto GL
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):89-90. PubMed ID: 1709212
    [No Abstract]   [Full Text] [Related]  

  • 25. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract]   [Full Text] [Related]  

  • 26. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
    Neumann A; Keller T; Jocham D; Doehn C
    Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Studies on the tumor markers in the germinal testicular tumors. Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG) and carcinoembryonic antigen (CEA) in germinal testicular tumors using an indirect immunoperoxidase method].
    Miki T
    Nihon Hinyokika Gakkai Zasshi; 1984 Mar; 75(3):503-22. PubMed ID: 6206269
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment options for stage I nonseminoma.
    Feldman DR
    J Clin Oncol; 2014 Dec; 32(34):3797-800. PubMed ID: 25366681
    [No Abstract]   [Full Text] [Related]  

  • 29. [Role of biochemical tumor markers in the diagnosis and monitoring of neoplastic processes].
    Szymendera J
    Nowotwory; 1982; 32(1-2):7-17. PubMed ID: 6184677
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of clinical stage I nonseminomatous germ cell testicular cancer.
    Choueiri TK; Stephenson AJ; Gilligan T; Klein EA
    Urol Clin North Am; 2007 May; 34(2):137-48; abstract viii. PubMed ID: 17484919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of seminoma: does a positive HCG influence prognosis?
    Bartsch G; Mikuz G; Frommhold H; Scheiber K
    Prog Clin Biol Res; 1985; 203():483-4. PubMed ID: 2421340
    [No Abstract]   [Full Text] [Related]  

  • 32. Testicular germ cell tumors: diagnosis, management, and the potential for cure.
    Katz ME; Grosbach AB; Wein A; Glick JH
    Cancer Clin Trials; 1978; 1(4):247-71. PubMed ID: 93029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of serum AFP, HCG, and CEA in testicular tumor].
    Miki T; Oda H; Kamei O; Saiki S; Kinouchi T; Kuroda M; Yoshida M; Kiyohara H; Usami M; Osafune M
    Nihon Hinyokika Gakkai Zasshi; 1983 Jul; 74(7):1236-47. PubMed ID: 6198548
    [No Abstract]   [Full Text] [Related]  

  • 34. [The importance of determining human chorionic gonadotropin and alpha fetoproteins in the diagnosis of testicular tumor recurrence].
    Kausitz J; Bohunický L; Hupka S
    Bratisl Lek Listy; 1985 Oct; 84(4):430-5. PubMed ID: 2415223
    [No Abstract]   [Full Text] [Related]  

  • 35. [Biological markers in cancer of the testis].
    Lotsberg J; Fosså SD; Klepp O; Orjasaeter H; Torjesen PA
    Tidsskr Nor Laegeforen; 1980 Apr; 100(12):688-90. PubMed ID: 6158120
    [No Abstract]   [Full Text] [Related]  

  • 36. Tumour markers in testicular tumours.
    Chisholm GD
    Prog Clin Biol Res; 1985; 203():81-91. PubMed ID: 2421346
    [No Abstract]   [Full Text] [Related]  

  • 37. Applications of biologic tumor markers in testicular cancer.
    Javadpour N
    Cancer Treat Rep; 1979; 63(9-10):1643-7. PubMed ID: 91433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serial monitoring of serum alpha-fetoprotein and chorionic gonadotropin in males with germ cell tumors.
    Thompson DK; Haddow JE
    Cancer; 1979 May; 43(5):1820-9. PubMed ID: 87255
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of radioimmunoanalysis for tumor markers in the diagnosis of carcinoma of the testes and prostate].
    Kausitz J
    Bratisl Lek Listy; 1988 Oct; 89(10):715-24. PubMed ID: 2463063
    [No Abstract]   [Full Text] [Related]  

  • 40. Alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Lange PH; McIntire KR; Waldmann TA; Hakala TR; Fraley EE
    J Urol; 1977 Oct; 118(4):593-6. PubMed ID: 72163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.